tiprankstipranks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
Holding BMRN?
Track your performance easily

BioMarin Pharmaceutical (BMRN) Financial Statements

1,983 Followers

BioMarin Pharmaceutical Financial Overview

BioMarin Pharmaceutical's market cap is currently ―. The company's EPS TTM is $1.66; its P/E ratio is 37.31; BioMarin Pharmaceutical is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $0.55. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 745.74M$ 712.03M$ 648.83M$ 646.21M$ 581.33M
Gross Profit$ 557.28M$ 581.57M$ 523.65M$ 510.73M$ 453.29M
EBIT$ 134.44M$ 132.14M$ 109.09M$ 24.83M$ 41.67M
EBITDA$ 154.16M$ 162.09M$ 136.44M$ 51.69M$ 68.49M
Net Income Common Stockholders$ 106.08M$ 110.75M$ 88.66M$ 20.38M$ 40.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 930.44M$ 1.22B$ 1.05B$ 1.07B$ 1.13B
Total Assets$ 6.85B$ 7.07B$ 6.87B$ 6.84B$ 6.76B
Total Debt$ 594.63M$ 1.09B$ 1.09B$ 1.09B$ 1.09B
Net Debt$ -335.82M$ -135.40M$ 41.38M$ 13.16M$ -39.86M
Total Liabilities$ 1.44B$ 1.78B$ 1.80B$ 1.89B$ 1.86B
Stockholders Equity$ 5.41B$ 5.29B$ 5.07B$ 4.95B$ 4.90B
Cash Flow-
Free Cash Flow$ 200.31M$ 96.92M$ 12.87M$ -9.21M$ 112.23M
Operating Cash Flow$ 221.48M$ 118.76M$ 46.97M$ 27.48M$ 135.65M
Investing Cash Flow$ -16.16M$ 90.48M$ -14.24M$ -64.96M$ -45.80M
Financing Cash Flow$ -499.13M$ 12.61M$ -42.79M$ 10.84M$ -788.00K
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

BioMarin Pharmaceutical Debt to Assets

BioMarin Pharmaceutical Cash Flow

BioMarin Pharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis